Literature DB >> 17221128

Serological markers and risk factors for hepatitis B and C viruses in patients infected with human immunodeficiency virus.

Alvaro Hoyos-Orrego1, Mónica Massaro-Ceballos, Marta Ospina-Ospina, Carolina Gómez-Builes, Nora Vanegas-Arroyave, Juan Tobón-Pereira, Javier Jaramillo-Hurtado, María Teresa Rugeles-López.   

Abstract

Both hepatitis B and hepatitis C viruses (HBV and HCV) infection are common in HIV-infected individuals as a result of shared risk factors for acquisition. A serological study for HBV and HCV was performed in 251 HIV-positive individuals from Medellín, Colombia. A qualitative RT-PCR for HCV was done in 90 patients with CD4+ T-cell count < 150 per mm(3). Serological markers for HBV infection were present in 97 (38.6%) patients. Thirty six of them (37.1%) had isolated anti-HBc. A multivariate analysis indicated that the following risk factors were significantly associated with the presence of these markers: age (OR = 1.05, 95% CI: 1.01-1.08), pediculosis pubis (OR = 1.83, 95% CI: 1.01-3.33), men who have sex with men and women (OR = 3.23, 95% CI: 1.46-7.13) and men who have sex only with men (OR = 3.73, 95% CI: 1.58-8.78). The same analysis restricted to women showed syphilis as the only significant risk factor. Thus, HBV infection was considerably associated with high risk sexual behavior. HCV was present in only two (0.8%) of HIV patients. Both of them were positive by RT-PCR and anti-HCV. This low frequency of HIV/HCV coinfection was probably due to the uncommon intravenous drug abuse in this population. The frequent finding of isolated anti-HBc warrants molecular approaches to rule out the presence of cryptic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17221128     DOI: 10.1590/s0036-46652006000600004

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  5 in total

1.  Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominance.

Authors:  Henry Bautista-Amorocho; Yeny Zulay Castellanos-Domínguez; Laura Andrea Rodríguez-Villamizar; Sindi Alejandra Velandia-Cruz; Jeysson Andrey Becerra-Peña; Ana Elvira Farfán-García
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

Review 2.  Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review.

Authors:  Fatima Mitiko Tengan; Karim Yakub Ibrahim; Bianca Peixoto Dantas; Caroline Manchiero; Mariana Cavalheiro Magri; Wanderley Marques Bernardo
Journal:  BMC Infect Dis       Date:  2016-11-09       Impact factor: 3.090

3.  A Serological Survey of Selected Papua New Guinea Blood Donors for Hepatitis B and Related Co-Infections.

Authors:  Francisca Varpit; Bruce Gummow
Journal:  Trop Med Infect Dis       Date:  2020-06-29

4.  [Epidemiology of hepatitis C virus infection in ColombiaEpidemiologia da infecção pelo vírus da hepatite C na Colômbia].

Authors:  María C López-Osorio; Mauricio Beltrán; María-Cristina Navas
Journal:  Rev Panam Salud Publica       Date:  2021-09-16

5.  A Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals.

Authors:  Geane L Flores; Adilson J de Almeida; Juliana C Miguel; Helena M Cruz; Moyra M Portilho; Letícia de P Scalioni; Vanessa A Marques; Lia Laura Lewis-Ximenez; Elisabeth Lampe; Livia Melo Villar
Journal:  Int J Environ Res Public Health       Date:  2016-03-11       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.